Detact Diagnostics

Netherlands
Delfzijl, Groningen, The Netherlands

Company profile

Detact Diagnostics company profile

Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff to determine bacterial presence on surface areas with an easy to use system: the b-Swab.

Business identity

Contact email
[email protected]
Phone number
+310615382382
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$2.3M
Last funding
Grant / $5.9M / 2025-11-07
Last equity funding
Series Unknown
Investors
4
Lead investors
4
Founders
1
Articles
1

Founders and investors

Founders

Joost Gazendam

Lead investors

Bill & Melinda Gates FoundationJM Molina InvestmentsNV NOMPacific 6 Enterprises

Investors

Bill & Melinda Gates FoundationJM Molina InvestmentsNV NOMPacific 6 Enterprises